A New Year comes. On January 2, 2019, the first working day, Duan Chenggang, a member of the Standing Committee of CPC Chongqing Municipal Committee, the secretary of the Party Working Committee of Liangjiang New Area and the director of the Management Committee, visited and inspected Chongqing Hemony Pharmaceutical Co., Ltd.
Liangjiang Investment Group, Industrial Group, Science and Technology Innovation Bureau, Economic Operation Bureau and the office of the Party Working Committee and Management Committee accompanied the delegation.
Lan Jianhua, chairman of Hemony Pharmaceutical Co., Ltd., introduced the company's development process to the delegation.
The delegation visited the production workshop, technical research and development center, product exhibition hall, etc., and listened to the introduction by Lan Jianhua, chairman of Hemony Pharmaceutical Co., Ltd. The delegation extended the full affirmation to the constant optimization of marketing system of Hemony, and its introduction of imported drugs, merger as well as development of generic drugs and building of production line construction to build its core competitiveness.
Duan Chenggang, a member of the Standing Committee, said that the pharmaceutical industry development is a matter of people's health and well-being, as it is related to the development of new kinetic energy. Liangjiang New Area attached great importance to the pharmaceutical industry development, so it is required to enhance the service consciousness in the future, actively build intellectual property protection system and industry exchange and cooperation platform system, promote the gathering of capital, technology, talent resources, and erect the whole industry ecology development chain.
The delegation visited the production workshop of Hemony in Chongqing.
Duan Chenggang emphasized that the Hemony is positioned itself with clear strategic goals, obvious industry advantages with huge development potential. He hoped that the enterprise would make full use of the favorable policy environment endowed by the new era, give full play to the advantages of the integration of research, production and marketing, deepen the mechanism for collaborative innovation, while strengthen the innovation, research and development, to ensure drug quality and safety, promote the healthy development of industries, and to make positive contributions to the public health while keep the company be more bigger and stronger.
Li Zhiliang, head of Chongqing Hemony Pharmaceutical Co., Ltd., accompanied the delegation.